MAVERICK THERAPEUTICS
Maverick Therapeutics is a biotech company focused on improving the lives of patients with solid tumor cancers by developing breakthrough T cell immunotherapies with improved safety and efficacy. Their highly innovative platform, COBRAâ„¢, is the most advanced bispecific T cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.
MAVERICK THERAPEUTICS
Social Links:
Industry:
Biotechnology
Address:
Brisbane, California, United States
Country:
United States
Website Url:
http://www.mavericktx.com
Status:
Active
Total Funding:
125 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Amazon Route 53 DMARC Vimeo AWS Global Accelerator Mailgun Comcast
Current Advisors List
Founder
Investors List
Takeda
Takeda investment in Venture Round - Maverick Therapeutics
MPM Capital
MPM Capital investment in Venture Round - Maverick Therapeutics
Official Site Inspections
http://www.mavericktx.com
- Host name: afe41c95a9e82f02c.awsglobalaccelerator.com
- IP address: 13.248.133.121
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109

More informations about "Maverick Therapeutics"
Takeda to Acquire Maverick Therapeutics to Advance T-Cell …
Mar 9, 2021 · Under the agreement, Takeda will obtain Maverick’s T-cell engager COBRAâ„¢ platform and a broad development portfolio, including Maverick’s lead development candidate …See details»
Maverick Therapeutics - LinkedIn
Follow us at https://www.linkedin.com/company/takeda-pharmaceuticals/ Maverick Therapeutics is pioneering the next generation of redirected T-cell targeted immunotherapies.See details»
Maverick Therapeutics - Craft
Maverick Therapeutics is a preclinical stage biotech company developing a class of T cell-redirecting antibody therapeutics. It offers COBRA, a platform designed to safely target solid …See details»
Maverick Therapeutics Company Overview, Contact Details
Jan 1, 2017 · Mavericktx is developing T-cell engagement platform created specifically to improve the utility of T-cell redirection therapy.See details»
Maverick Therapeutics - Crunchbase Company Profile & Funding
Maverick Therapeutics is a biotech company focused on improving the lives of patients with solid tumor cancers by developing breakthrough T cell immunotherapies with improved safety and …See details»
Maverick Therapeutics Announces Key Executive Promotion and …
Aug 31, 2020 · Learn more about the new Scientific Advisory Board appointees, here: https://www.mavericktx.com/about/#scientific-advisory-board. About MVC-101.See details»
Takeda to Acquire Maverick Therapeutics | citybiz
Mar 10, 2021 · OSAKA, Japan & BRISBANE, Calif.– ( BUSINESS WIRE )–Takeda Pharmaceutical Company Limited today announced the exercise of its option to acquire …See details»
Maverick Therapeutics to Unveil Pre-Clinical Data on Novel COBRA
Mar 30, 2019 · Maverick Therapeutics is pioneering the next generation of potent, selective immunotherapies for solid tumors by focusing on applying deep integrated expertise in drug …See details»
Takeda to Acquire Maverick Therapeutics to Advance T-Cell …
Mar 10, 2021 · Takeda Pharmaceutical Company Limited announced the exercise of its option to acquire Maverick Therapeutics, Inc. a private biopharmaceutical company pioneering …See details»
Maverick Therapeutics Announces First Peer-Reviewed Publication ...
Aug 6, 2020 · Maverick Therapeutics’ COBRAâ„¢ platform is the most mature conditionally active bispecific T cell engaging platform designed to safely target a broad range of solid tumors with …See details»
Maverick Therapeutics Announces Pipeline Updates for its
Jun 3, 2020 · Based on the promise of the Company’s early-stage research, Maverick entered a five-year drug development project with Takeda. For further information, please visit …See details»
Maverick Therapeutics - PitchBook
Developer of a novel biologics platform designed to eliminate the toxicity challenges in the treatment of cancer.See details»
Ex-Pacira Exec Joins Bay Area Maverick Therapeutics as CEO
Aug 10, 2017 · In early 2017 Maverick announced a series of transactions providing $125 million of committed funding from Takeda Pharmaceutical Company Ltd, MPM BioVentures 2014 and …See details»
Takeda to Acquire Maverick Therapeutics to Advance T ... - Takeda …
Mar 9, 2021 · Under the agreement, Takeda will obtain Maverick’s T-cell engager COBRAâ„¢ platform and a broad development portfolio, including Maverick’s lead development candidate …See details»
Takeda to Acquire Maverick Therapeutics to Advance T-Cell
Mar 9, 2021 · After closing of the transaction, Maverick employees, including its team of talented scientists, will join Takeda’s Research & Development organization. This press release …See details»
Maverick Therapeutics Reveals Preclinical Data from ... - Business …
Aug 19, 2020 · Maverick Therapeutics’ COBRAâ„¢ platform is the most mature conditionally active bispecific T cell engaging platform designed to safely target a broad range of solid tumors with …See details»
Maverick Therapeutics, Inc. | Insights
Dec 21, 2021 · Nearly 3,500 gene, cell and RNA therapies are in development across the world, with 77 of them in Phase III trials, and the first quarter of 2021 saw 13 start-ups raise $480m …See details»
Russian journalist convicted of cooperating with a foreign …
2 days ago · The organization has been fined millions of dollars by Russi and was outlawed in the country in February. Alsu Kurmasheva , a Radio Free Europe/Radio Liberty journalist with U.S …See details»
Maverick Therapeutics Announces Pipeline Updates for its …
Jun 3, 2020 · Based on the promise of the Company’s early-stage research, Maverick entered a five-year drug development project with Takeda. For further information, please visit …See details»
What is a matrix organization and how does it work? - Asana
Feb 22, 2024 · What is a matrix organization and how does it work? A matrix organization is a company structure where teams report to multiple leaders. The matrix design keeps open …See details»